- What's Tisch?
- Stem Cell Trial
- Get Involved
The Tisch MSRCNY – and our recent research around the potential causes of sporadic ALS (sALS), using our novel animal model – have been featured in an article in ALS News Today. Based on our research, which was recently published in Brain Communications, this piece in ALS News Today highlights the significant implications that the study has for understanding the cause of sALS (the form of the disease affecting 90% of patients), and the impact these results could have on developing more effective treatments for ALS.
You can read the full article here on the ALS News Today website.
521 West 57th Street
New York, NY 10019
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.